<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">469094028</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323133025.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170328e19921201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF02576290</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF02576290</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Cardiac glycosides in the treatment of experimental overdose with calcium-blocking agents</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[M. Ramo, I. Grupp, M. Pesola, J. Heikkila, K. Luomanmaki, T. Schroder, G. Grupp]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Summary: The ability of digitalis compounds to counteract calcium antagonist overdose was studied in anesthetized dogs (n=6, 13.5±0.7 kg) and isolated trabeculae from human hearts (n=7). Digitalis caused by increasing intracellular cytosolic Ca2+ concentration through Na+/Ca2+-exchange across the cell membrane, was postulated to overcome the detrimental effects of excessive slow calcium-channel blockade. In anesthetized dogs, an infusion of verapamil (40 mg/30 min, i.v.) decreased mean arterial pressure from 88±6 to 66±6 mm Hg (P&lt;0.05), reduced systemic vascular resistance (SVR) from 3838±916 to 2200±669 dyne·s/cm5 (P&lt;0.05), and induced total atrio-ventricular (A-V) block in three animals. Stroke volume (SV) remained unchanged. Administration (i.v.) of NaCl (0.9%, 200 ml) and calcium gluconate (100 mg)—to increase the availability of Na+ and Ca2+—together with atropine (0.2 mg)—to block the parasympathetic effects of digoxin on A-V conduction—increased left ventricular contractility (15%) but had no significant effects on blood pressure, SV, or A-V block. Digoxin (0.125 mg) returned sinus rhythm in all dogs and, by increasing SVR (P&lt;0.05) and left ventricular contractility (P&lt;0.05), returned arterial pressures to baseline. Because of increased afterload, SV decreased slightly (15%) despite increased cardiac contractility. In experiments with isolated trabeculae from diseased human hearts TA 3090 (Clentiazem) depressed contractile force and ouabain, another glycoside, restored contractile force within 30 min. Ouabain also counteracted the depression produced by anipamil, nifedipine, and amlodipine. In conclusion, these experimental results indicate that administration of digoxin, combined with atropine, may be beneficial in the treatment of verapamil overdose.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1992</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Ca2+ antagonists</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Poisoning</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Cardiac glycosides</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Atropine</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ramo</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Cincinnati, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Grupp</subfield>
   <subfield code="D">I.</subfield>
   <subfield code="u">Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Cincinnati, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Pesola</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Department of Physiology, University of Oulu, Department of Internal Medicine, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Heikkila</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Department of Physiology, University of Oulu, Department of Internal Medicine, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Luomanmaki</subfield>
   <subfield code="D">K.</subfield>
   <subfield code="u">Department of Physiology, University of Oulu, Department of Internal Medicine, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Schroder</subfield>
   <subfield code="D">T.</subfield>
   <subfield code="u">Department of Surgery, University of Oulu, Department of Surgery, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Grupp</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Cincinnati, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Research in Experimental Medicine</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">192/1(1992-12-01), 335-343</subfield>
   <subfield code="x">0300-9130</subfield>
   <subfield code="q">192:1&lt;335</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">192</subfield>
   <subfield code="o">433</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF02576290</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF02576290</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ramo</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Cincinnati, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Grupp</subfield>
   <subfield code="D">I.</subfield>
   <subfield code="u">Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Cincinnati, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Pesola</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Department of Physiology, University of Oulu, Department of Internal Medicine, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Heikkila</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Department of Physiology, University of Oulu, Department of Internal Medicine, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Luomanmaki</subfield>
   <subfield code="D">K.</subfield>
   <subfield code="u">Department of Physiology, University of Oulu, Department of Internal Medicine, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Schroder</subfield>
   <subfield code="D">T.</subfield>
   <subfield code="u">Department of Surgery, University of Oulu, Department of Surgery, University of Helsinki, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Grupp</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Cincinnati, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Research in Experimental Medicine</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">192/1(1992-12-01), 335-343</subfield>
   <subfield code="x">0300-9130</subfield>
   <subfield code="q">192:1&lt;335</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">192</subfield>
   <subfield code="o">433</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
